Abstract
Tyrosinase (EC 1.14.18.1) is known to be the rate-limiting enzyme responsible for catalyzing the first two steps in the synthesis of melanin pigments that determine the coloring of hair, skin and eyes. Tyrosinase catalyzes two- sequence distinct bio-reactions in pigment productions: L-tyrosine to L-dopa (hydroxylation); and L-dopa to dopaquinone (oxidation). The inhibition of tyrosinase has been established as one of the major strategies to regulate the production of melanin and the inhibitors are used to treat hyper-pigmentation and other unwanted effects from melanogenesis. There are now a variety of medicaments inhibiting melanin synthesis to treat excess melanin production or hyper-pigmentation of human skin, including the usage of natural plant extracts or chemically synthesized compounds. Recently, due to an increasing emphasis on healthy concepts, attention has been drawn to the usage of naturally produced crude materials and drugs in cosmetics and pharmaceutical applications. In this review, we demonstrate melanogenic inhibitory factors such as flavonoids, stilbenes, simple phenolics, furans, triterpenes, alkaloids, and other synthetic compounds. The structure-activity relationships are classified in terms of their inhibition of tyrosinase functions and copper chelating activity.
Keywords: Alkaloids, flavonoids, furans, melanin, tyrosinase inhibitor, stilbenes, simple phenolics, triterpenes.
Current Organic Chemistry
Title:An Updated Organic Classification of Tyrosinase Inhibitors on Melanin Biosynthesis
Volume: 19 Issue: 1
Author(s): Chung-Yi Chen, Li-Ching Lin, Wen-Feng Yang, Jennifer Bordon and Hui-Min D. Wang
Affiliation:
Keywords: Alkaloids, flavonoids, furans, melanin, tyrosinase inhibitor, stilbenes, simple phenolics, triterpenes.
Abstract: Tyrosinase (EC 1.14.18.1) is known to be the rate-limiting enzyme responsible for catalyzing the first two steps in the synthesis of melanin pigments that determine the coloring of hair, skin and eyes. Tyrosinase catalyzes two- sequence distinct bio-reactions in pigment productions: L-tyrosine to L-dopa (hydroxylation); and L-dopa to dopaquinone (oxidation). The inhibition of tyrosinase has been established as one of the major strategies to regulate the production of melanin and the inhibitors are used to treat hyper-pigmentation and other unwanted effects from melanogenesis. There are now a variety of medicaments inhibiting melanin synthesis to treat excess melanin production or hyper-pigmentation of human skin, including the usage of natural plant extracts or chemically synthesized compounds. Recently, due to an increasing emphasis on healthy concepts, attention has been drawn to the usage of naturally produced crude materials and drugs in cosmetics and pharmaceutical applications. In this review, we demonstrate melanogenic inhibitory factors such as flavonoids, stilbenes, simple phenolics, furans, triterpenes, alkaloids, and other synthetic compounds. The structure-activity relationships are classified in terms of their inhibition of tyrosinase functions and copper chelating activity.
Export Options
About this article
Cite this article as:
Chen Chung-Yi, Lin Li-Ching, Yang Wen-Feng, Bordon Jennifer and D. Wang Hui-Min, An Updated Organic Classification of Tyrosinase Inhibitors on Melanin Biosynthesis, Current Organic Chemistry 2015; 19 (1) . https://dx.doi.org/10.2174/1385272819666141107224806
DOI https://dx.doi.org/10.2174/1385272819666141107224806 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cytokine/Antibody Complexes: An Emerging Class of Immunostimulants
Current Pharmaceutical Design A3 Receptor Ligands: Past, Present and Future Trends
Current Topics in Medicinal Chemistry Drug Delivery Systems for Prevention and Treatment of Osteoporotic Fracture
Current Drug Targets HIV-1 Vpr: Enhancing Sensitivity of Tumors to Apoptosis
Current Drug Delivery Anticancer Therapeutic Strategies Based on CDK Inhibitors
Current Pharmaceutical Design Targeted Therapy in Colorectal Cancer: Current Status and Future Challenges
Current Medicinal Chemistry Recent Advances in Two-Photon Photodynamic Therapy
Anti-Cancer Agents in Medicinal Chemistry Cancer Treatment-Induced Cardiotoxicity: a Cardiac Stem Cell Disease?
Cardiovascular & Hematological Agents in Medicinal Chemistry Targeting p53-MDM2 Interaction Using Small Molecule Inhibitors and the Challenges Needed to be Addressed
Current Drug Targets Indole Compounds Against Breast Cancer: Recent Developments
Current Drug Targets Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer
Current Neurovascular Research New Treatments for Cutaneous Metastatic Melanoma: MAPK Pathway-Targeted and Immune Based Therapies
Anti-Cancer Agents in Medicinal Chemistry Can PET Imaging Facilitate Optimization of Cancer Therapies?
Current Pharmaceutical Design Anti-Apoptotic Actions of Insulin-Like Growth Factors: Lessons from Development and Implications in Neoplastic Cell Transformation
Current Pharmaceutical Design Radiolabeled Probes Targeting Tyrosine-Kinase Receptors For Personalized Medicine
Current Pharmaceutical Design Review on Patents for Ubiquitin-Proteasome Inhibitor as Medical Advance in Major Human Diseases
Recent Patents on Biomedical Engineering (Discontinued) Glioma Stem Cell Maintenance: The Role of the Microenvironment
Current Pharmaceutical Design Recent Advances in pH-Sensitive Polymeric Nanoparticles for Smart Drug Delivery in Cancer Therapy
Current Drug Targets Regulatory T Cells and Skin Tumors
Recent Patents on Inflammation & Allergy Drug Discovery Intraocular Immune Mechanisms in Uveitis
Current Immunology Reviews (Discontinued)